Skip to main content

Table 1 Summary of studies identified in systematic literature review of Incidence of influenza virus infection among pregnant women

From: Incidence of influenza virus infection among pregnant women: a systematic review

Study

Outcome assesseda

Pandemic or seasonal

Study Design

Methodology

Denominator calculation

Dates of surveillance

Lab Test

Country (WHO Region) b

Country Income Level

Creanga 2010

HA, ICU, D

Pandemic

Case series

Retrospective chart review: pregnant women hospitalized with confirmed H1N1 identified through “enhanced surveillance.” Testing performance only when requested by hospital.

Estimation using 2007 vital registration data (similar approach as in Jamieson et al.)

05/01/2009–06/30/2009

RT-PCR

US (PAHO)

High

Doyle 2013

SI, HA, ICU, D

Pandemic

Case series

Cases of pH1N1-confirmed acute respiratory illness reported by health providers to state of Florida

Florida birth registry data

04/24/2009–05/31/2010

RT-PCR or viral culture

US (PAHO)

High

Griffiths 1980

I

Seasonal

Cohort

Serological testing of women “booked” for antenatal care at one hospital in England during three years. Only women with postpartum specimens available were included.

Number of study participants

05/1975–11/1975;

12/1975–06/1976;

08/1976–04/1977

HI serology with 4-fold rise in antibody titer

UK (EURO)

High

Hardy 1961

I

Pandemic

Cohort

All pregnant women treated at Johns Hopkins Obstetrical Prenatal Clinic, with blood samples taken and questionnaires about symptoms administered monthly through delivery. Anyone with high HI titer was considered a case.

Number of study participants

10/14/1957–02/01/1958

Complement Complement fixation or HI test; no increase in titers required to be considered a case

US (PAHO)

High

Irving 2000

I

Seasonal

Cohort

Women delivering at two hospitals in Nottingham, England with available antenatal and postnatal sera.

Number of study participants

05/1993–07/1994

Single radial hemolysis and paired specimens for HI titer

UK (EURO)

High

Jamieson 2009

SI, HA, ICU, D

Pandemic

Case series

Pregnant women with confirmed or probable H1 infection reported by states to CDC as part of “enhanced” surveillance.

US Census bureau data

04/15/2009–05/18/2009

Confirmed: RT-PCR or viral culture+for H1. Probable: RT-PCR flu A+ but (−) for known subtypes

US (PAHO)

High

Knight 2011

ICU, D

Pandemic

Case series

Cases of H1 lab-confirmed ICU admission among pregnant women in Australia and New Zealand reported to Australian and New Zealand Intensive Care (ANZIC) study. Cases in UK reported to UK Obstetric Surveillance System.

National statistics on pregnancies combined with total birth data

AUS/NZ:

06/01/2009–08/31/2009

UK:

09/01/2009–01/31/2010

Not stated in manuscript (but referenced)

Australia and New Zealand (WPRO)

UK (EURO)

High

Madhi 2014

SI

Seasonal

Randomized Clinical trial

RCT of influenza vaccine efficacy. All participants with ILI or unknown respiratory illness were tested for influenza.

All women enrolled in placebo arm of study

03/2011–08/2011;

03/2012–07/2012

RT-PCR

South Africa (AFRO)

Upper-Middle

Yates 2010c

HA, ICU, D

Pandemic

Case series

Clinician-reported of H1-confirmed pregnant women admitted to 221/223 hospitals with consultant-led maternity units in the UK. Surveillance included zero-reporting and follow-up of reported cases.

Birth data from UK office for national statistics

09/01/2009–01/31/2010

Not specified

UK (EURO)

High

  1. aOutcomes are abbreviated as follows: I Infection, SI Symptomatic Infection, HA Hospital admission, ICU ICU admission, D Death
  2. bWHO regions are abbreviated as follows: PAHO Americas, EURO Europe, AFRO Africa, WPRO Western Pacific
  3. cThe Yates study described same population as described in Knight study; therefore only Knight study results were included in the ICU and death tables